Els ß-lactàmics

Authors

  • Elisenda Miró
  • Raúl-Jesús Mesa
  • Alba Rivera

Abstract

β-lactam antibiotics are among the most commonly used antimicrobial agents. These agents have very favourable pharmacokinetic properties. Their action is relatively independent of plasma concentration, little toxicity and a broad therapeutic margin. They include penicillins, cephalosporins, monobactams, and carbapenems. All of them have a β-lactam ring, which is essential for antibacterial activity. β-lactam antibiotics are bactericidal because they act on PBPs, which are involved in bacterial cell-wall synthesis. Their spectrum of activity included Grampositive and Gram-negative bacteria, but not mycoplasmae, rickettsiae and mycobacteria. The mechanism of resistance to β-lactams involved mutations in PBPs resulting in reduced affinity for β-lactam antibiotics, reduced uptake due to changes in the cell wall, active efflux, and β-lactamase production. Resistance to β-lactam antibiotics has been a problem for as long as these drugs have been used in clinical practice. Their spectrum has increased over the years with the incorporation of new molecules having greater activity against gram-negative bacilli. Nevertheless, the progressive emergence of acquired resistance has limited the empirical use of β-lactams and their efficacy in certain situations.

Published

2006-02-01

Issue

Section

Principals grups d'agents antibacterians